WO2014199397A3 - Process for the preparation of liraglutide - Google Patents

Process for the preparation of liraglutide Download PDF

Info

Publication number
WO2014199397A3
WO2014199397A3 PCT/IN2014/000384 IN2014000384W WO2014199397A3 WO 2014199397 A3 WO2014199397 A3 WO 2014199397A3 IN 2014000384 W IN2014000384 W IN 2014000384W WO 2014199397 A3 WO2014199397 A3 WO 2014199397A3
Authority
WO
WIPO (PCT)
Prior art keywords
liraglutide
preparation
iiraglutide
fragments
synthesized
Prior art date
Application number
PCT/IN2014/000384
Other languages
French (fr)
Other versions
WO2014199397A2 (en
Inventor
Ananda Kuppanna
Maria Bhaskara Reddy KOMMA REDDY
Sreelatha VENJIVAKA
Mallikarjuna Sarma Dokka
Bulliraju Kamana
Original Assignee
Mylan Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mylan Laboratories Ltd filed Critical Mylan Laboratories Ltd
Publication of WO2014199397A2 publication Critical patent/WO2014199397A2/en
Publication of WO2014199397A3 publication Critical patent/WO2014199397A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons

Abstract

The present invention relates to an improved process for the synthesis of Iiraglutide or pharmaceutically acceptable salts by hybrid approach. The fragments are synthesized by solid phase synthesis approach and the Iiraglutide is synthesized by making use of the fragments in solution phase.
PCT/IN2014/000384 2013-06-11 2014-06-09 Process for the preparation of liraglutide WO2014199397A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2536CH2013 2013-06-11
IN2536/CHE/2013 2013-06-11

Publications (2)

Publication Number Publication Date
WO2014199397A2 WO2014199397A2 (en) 2014-12-18
WO2014199397A3 true WO2014199397A3 (en) 2015-01-29

Family

ID=51417545

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2014/000384 WO2014199397A2 (en) 2013-06-11 2014-06-09 Process for the preparation of liraglutide

Country Status (1)

Country Link
WO (1) WO2014199397A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107286234A (en) * 2016-03-31 2017-10-24 深圳翰宇药业股份有限公司 A kind of method for reducing and/or removing default peptide in Solid-phase synthesis peptides
CN107903318A (en) * 2017-12-29 2018-04-13 江苏诺泰澳赛诺生物制药股份有限公司 A kind of method for purifying Liraglutide

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017127007A1 (en) 2016-01-20 2017-07-27 Poypeptide Laboratories Holding (Ppl) Ab METHOD FOR PREPARATION OF PEPTIDES WITH psWANG LINKER
EP3205660A1 (en) * 2016-02-10 2017-08-16 Polypeptide Laboratories Holding (PPL) AB Method for preparation of peptides with pswang linker
EP3205664A1 (en) * 2016-02-11 2017-08-16 Polypeptide Laboratories Holding (PPL) AB Method for preparation of liraglutide using bal linker
US11117946B2 (en) * 2016-03-23 2021-09-14 Bachem Holding Ag Method for preparing glucagon-like peptides
CA3018627A1 (en) 2016-03-23 2017-09-28 Bachem Holding Ag Purification of glucagon-like peptide 1 analogs
WO2018032521A1 (en) * 2016-08-19 2018-02-22 深圳市健元医药科技有限公司 Method for synthesizing liraglutide
MX2019006711A (en) * 2016-12-10 2019-10-30 Biocon Ltd Synthesis of liraglutide.
CN107022021A (en) * 2017-03-24 2017-08-08 吉尔生化（上海）有限公司 A kind of solid-phase synthesis of Liraglutide
WO2019069274A1 (en) * 2017-10-04 2019-04-11 Chemical & Biopharmaceutical Laboratories Of Patras S.A. A process for preparing a glucagon-like peptide
CN111757891A (en) 2018-03-09 2020-10-09 恩细贝普有限公司 Chemical-enzymatic synthesis of somaglutide, liraglutide and GLP-1
CN111819191A (en) 2018-03-09 2020-10-23 恩细贝普有限公司 Chemoenzymatic synthesis of liraglutide, somaglutide and GLP-1
CN110894227A (en) * 2018-09-13 2020-03-20 南京华威医药科技集团有限公司 Solid-phase synthesis method of liraglutide
EP3894387A4 (en) * 2018-12-12 2023-07-19 Levim Biotech LLP Acylation process for preparation of n-substituted peptide
EP3897570A1 (en) 2018-12-19 2021-10-27 KRKA, d.d., Novo mesto Pharmaceutical composition comprising glp-1 analogue
WO2020161664A2 (en) * 2019-02-06 2020-08-13 Enzene Biosciences Limited Glucagon-like peptide-1 (glp-1) agonist analog, process of preparation and uses thereof
JP2022526115A (en) 2019-03-19 2022-05-23 エンゼン・バイオサイエンシズ・リミテッド Glucagon-like peptide-1 (GLP-1) receptor agonist and its analog manufacturing process
WO2020202182A1 (en) * 2019-03-29 2020-10-08 Mylan Laboratories Limited Process for the preparation of abaloparatide
CN111944038B (en) * 2019-04-30 2023-06-13 深圳市健元医药科技有限公司 Synthetic method of somalupeptide
CN112010961B (en) * 2019-05-31 2023-05-16 深圳市健元医药科技有限公司 Solid-liquid synthesis method of somalupeptide
WO2021123228A1 (en) 2019-12-18 2021-06-24 Krka, D.D., Novo Mesto Pharmaceutical composition comprising glp-1 analogue
US20230044268A1 (en) * 2019-12-23 2023-02-09 Shilpa Medicare Ltd An improved process for preparation of liraglutide
CN113135989B (en) * 2020-01-20 2023-10-03 深圳市健元医药科技有限公司 Method for preparing liraglutide
CN113278054B (en) * 2021-06-24 2023-03-24 安徽大学 Cyclic peptide combined with new coronavirus RBD site as well as preparation method and application thereof
CN113480633B (en) * 2021-08-04 2023-08-25 成都诺和晟泰生物科技有限公司 Preparation method of tidulcin
CN113861273B (en) * 2021-12-06 2022-03-25 浙江湃肽生物有限公司深圳分公司 Synthesis method of myristoyl pentapeptide-4

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268343B1 (en) * 1996-08-30 2001-07-31 Novo Nordisk A/S Derivatives of GLP-1 analogs
WO2012062803A1 (en) * 2010-11-09 2012-05-18 Novo Nordisk A/S Double-acylated glp-1 derivatives
WO2013037266A1 (en) * 2011-09-14 2013-03-21 深圳翰宇药业股份有限公司 Method for solid phase synthesis of liraglutide

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268343B1 (en) * 1996-08-30 2001-07-31 Novo Nordisk A/S Derivatives of GLP-1 analogs
WO2012062803A1 (en) * 2010-11-09 2012-05-18 Novo Nordisk A/S Double-acylated glp-1 derivatives
WO2013037266A1 (en) * 2011-09-14 2013-03-21 深圳翰宇药业股份有限公司 Method for solid phase synthesis of liraglutide

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107286234A (en) * 2016-03-31 2017-10-24 深圳翰宇药业股份有限公司 A kind of method for reducing and/or removing default peptide in Solid-phase synthesis peptides
CN107286234B (en) * 2016-03-31 2021-06-08 深圳翰宇药业股份有限公司 Method for reducing and/or removing default peptide in polypeptide solid phase synthesis
CN107903318A (en) * 2017-12-29 2018-04-13 江苏诺泰澳赛诺生物制药股份有限公司 A kind of method for purifying Liraglutide

Also Published As

Publication number Publication date
WO2014199397A2 (en) 2014-12-18

Similar Documents

Publication Publication Date Title
WO2014199397A3 (en) Process for the preparation of liraglutide
HRP20181696T1 (en) Process for the preparation of lysin-glutamic acid dipeptide derivatives
WO2014145214A3 (en) Inhibitors of prmt5 and methods of their use
EA201491672A1 (en) HETEROCYCLINE COMPOUNDS AS MEK INHIBITORS
WO2013151736A3 (en) In vivo production of proteins
IN2015KN00262A (en)
MX361653B (en) Process for preparing bile acid derivatives.
IN2015DN01119A (en)
WO2012025944A3 (en) Sitagliptin, salts and polymorphs thereof
MY162397A (en) Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
WO2013121235A3 (en) Process for preparation of dronedarone by removal of hydroxyl group
WO2015029074A3 (en) Compositions of eltrombopag
IN2014DN06964A (en)
WO2013168176A3 (en) Process for preparation of fosaprepitant and salt thereof
WO2014141294A3 (en) An improved process for the synthesis of melphalan and the hydrochloride salt
IN2015DN00085A (en)
WO2015087343A3 (en) An improved process for the preparation of nilotinib and pharmaceutically acceptable salts thereof
WO2014178064A3 (en) "an improved process for the preparation of fluvoxamine maleate"
WO2014008204A3 (en) Structures of proteasome inhibitors and methods for synthesizing and use thereof
WO2015102017A8 (en) Processes for the preparation of lorcaserin
MX364929B (en) 5-amino-quinoline-8-carboxamide derivatives as 5-ht4 receptor agonists.
WO2013114397A3 (en) Pharmaceutically acceptable salt of brinzolamide and composition thereof
WO2014041558A3 (en) Process for preparation of crystalline etoricoxib
WO2011095989A3 (en) An improved process for the preparation of enfuvirtide
WO2014147464A3 (en) Novel process for the preparation of tolcapone

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 14755923

Country of ref document: EP

Kind code of ref document: A2